ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

25 3月 2026 10:19:54 条件 NetDania Notify

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease

13 1月 2026 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

08 1月 2026 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

06 1月 2026 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

18 12月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

12 12月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

26 11月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

25 11月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference

19 11月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

18 11月 2025 07:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

14 11月 2025 09:45:19 条件 NetDania Notify

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

14 11月 2025 07:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

13 11月 2025 11:34:52 条件 NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

10 11月 2025 09:48:54 条件 NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

07 11月 2025 10:02:06 条件 NetDania Notify

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

29 10月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

10 10月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

02 10月 2025 07:35:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

02 10月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

30 9月 2025 08:30:00 条件 Nasdaq GlobeNewswire